E. Tuzcu
The Lancet · 2000–2018
A researcher in the Science corpus: 28 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Who trusts E. Tuzcu overall
Papers from E. Tuzcu's perspective
Ordered by how strongly the researchers E. Tuzcu trusts endorse each paper. Same corpus, a different order for every researcher.
- Intravascular ultrasound: novel pathophysiological insights and current clinical applications. (Circulation)
- Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
- Effect of torcetrapib on the progression of coronary atherosclerosis. (New England Journal of Medicine)
- Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. (Journal of the American Medical Association (JAMA))
- Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. (Journal of the American Medical Association (JAMA))
- Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. (Journal of the American Medical Association (JAMA))
- Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus (Annals of Internal Medicine)
- Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. (European Heart Journal-Cardiovascular Imaging)
- Guidelines on the Management of Valvular Heart disease (Version 2012)
- Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular… (European Heart Journal-Cardiovascular Imaging)
Their papers
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) — 1,480 citations
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) — 2,896 citations
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) — 8,401 citations
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) — 4,276 citations
- Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) — 632 citations
- Staging classification of aortic stenosis based on the extent of cardiac damage (2017) — 627 citations
- Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) — 2,211 citations
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) — 4,590 citations
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. (2016) — 5,345 citations
- Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015 (2016) — 1,771 citations
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) — 5,659 citations
- 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. (2015) — 795 citations
- 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. (2015) — 1,499 citations
- Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. (2013) — 751 citations
- Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. (2013) — 604 citations
- Transcatheter versus surgical aortic-valve replacement in high-risk patients. (2011) — 5,975 citations
- Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. (2008) — 890 citations
- Effect of torcetrapib on the progression of coronary atherosclerosis. (2007) — 887 citations
- Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. (2006) — 2,091 citations
- Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease (2005) — 745 citations